July 19, 2012
The patents for Pfizer Inc.'s blockbuster nerve pain drug Lyrica are valid, meaning Teva Pharmaceuticals Industries Ltd., Mylan Pharmaceuticals Inc. and others can't sell their planned generic versions, a Delaware federal judge said Thursday.